Could the CBD Market Have Reached a Saturation Point?

February 26, 2020 09:00:42

The past few years have seen an upsurge in cannabidiol’s (CBD) popularity. The hemp extract was barely known three years ago, but just a year after legalization, the CBD market is already worth millions in sales, with earnings projected from $591 million to $22 billion by 2022, according to the Brightfield Group.

Like all cannabinoids, cannabidiol has medicinal properties, and limited research has found that it can be effective against a number of ailments, ranging from high blood pressure and insomnia to chronic pain and anxiety. On top of that, it doesn’t have the side effects pharmaceuticals are known to cause, making it an extremely attractive option for people looking for…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.